|
|
 |
 |
|
Peter's duties include managing the venture capital and other technology investment activities of Connecticut Innovations. He has over 11 years of early-stage investing experience in over 20 private equity investments and has served as a director or board representative for nine companies, playing key roles in originating, managing, and exiting these investments.
Peter joined CI as a finance associate in 1995, after having served as a senior accountant at Ernst & Young LLP. He was later promoted to controller of CI. He then joined CI's investment team as a director, investments, and was subsequently promoted to managing director, investments. In 2006, Peter was promoted to the positions of executive vice president and chief investment officer. In 2007, Peter was named president and executive director.
Peter is a certified public accountant and a chartered financial analyst. He is a graduate of the University of Connecticut, with a bachelor's degree in business administration, and he holds a master's degree in business administration from the University of Hartford. Peter also served six years in the Connecticut Army National Guard.
Peter is member of the board of CYA Technologies, Inc., Post-N-Track and NetKey, Inc. He is a board observer of Perimeter eSecurity and Transaction Methods, Inc.
|
 |
|
Kevin manages the $46 million Connecticut BioScience Facilities Fund that invests in the build-out of wet laboratory space and analyses venture capital investment opportunities for Connecticut Innovations.
Kevin was formerly employed by the Connecticut Department of Economic and Community Development (DECD), where he was director of the Office of BioScience, responsible for client interaction, bioscience business recruitment, bioscience related public policy strategy and day-to-day operations of the office. Prior to that, he was director of business recruitment in DECD's Business Recruitment and Industry Clusters Division, negotiating relocation incentive packages for both large and small corporate development projects. He holds a master of business administration degree in business management from Quinnipiac University.
Kevin is a member of the board of Oil Purifications Systems, Inc. and RemoTV and a board observer of Rib-X Pharmaceuticals, Inc.
|
 |
|
Stepheni has been with Connecticut Innovations since 1992. She helps with the due diligence process and assists the investment team. Stepheni joined the investment team in 1999 as an investment analyst, screening inquiries and tracking the progress of potential investment clients. Previously, she served as finance associate, responsible for legislative reporting and investment tracking. Prior to joining CI, Stepheni worked for several years in retail management and law firm administration. Stepheni holds a bachelor's degree in business management and human resource development from the University of Connecticut, as well as a master's degree in business administration from the University of Hartford.
|
 |
|
Pauline joined Connecticut Innovations in 2002 as its controller. In May 2005 Pauline joined the investment team as a director of investments and in August 2007, Pauline was made managing director of investments. In addition to being responsible for initiating and closing deals, Pauline manages the investment associates and the deal team support staff. Prior to joining CI, Pauline was controller of an early-stage software development company. Pauline joined CI with over ten years of experience in both manufacturing and service organizations and began her career at Ernst & Young, LLP. She graduated magna cum laude with a bachelor's degree in accounting from the University of Connecticut and is a registered certified public accountant in the State of Connecticut.
Pauline is a member of the board of Retail Optimization, Inc., Environmental Energy Services, Inc., New Ortho Polymers and XLerant, Inc. She is a board observer of Premise Corporation, CGI Pharmaceuticals, Inc., eNR Services, Inc. and SmartEquip, Inc.
|
 |
|
Julie, director, business investment and analysis, has been with Connecticut Innovations since 1993 and is responsible for assisting the investment team with due diligence on investments. She also screens inquiries and tracks progress on potential investment clients. Julie maintains the information and resources for all staff. Previously, Julie worked as a media specialist in Connecticut school systems for 15 years, as well as in public libraries. Julie graduated from the College of St. Theresa, Kansas City, with a bachelor of arts degree and attended Southern Connecticut University as a library science major.
|
 |
|
Maneesh joined Connecticut Innovations as a director of investments in 2006 and is responsible for sourcing, evaluating, investing in and managing portfolio companies primarily in the software sector.
In some ways, this was a homecoming for Sagar. CI was an investor in a Shelton-based software company that Sagar co-founded and was instrumental in growing, NeuVis (acquired by IBM Rational). He brings over ten years of hands-on operational experience with technology start-ups, such as NeuVis, DataEase and Vendavo, to CI. In addition, Sagar worked with various Fortune 500 companies as a management consultant at Booz Allen Hamilton. Over the past decade, he has held positions in corporate and business development, enterprise sales, product marketing and executive management.
Sagar graduated magna cum laude from Ohio Wesleyan University with a bachelor of arts degree in economics management and earned a master of business administration degree from Columbia Business School. He is actively involved with and has served as a speaker at events hosted by the Connecticut Venture Group (CVG), The Indus Entrepreneurs (TIE) TriState, Yale Entrepreneurial Society (YES), Connecticut Technology Council (CTC) and Columbia Business School.
Maneesh is a member of the board of Retail Optimization, Inc., frevvo, Inc., Legitime Technologies, Inc., NetKey, Inc., Keisense and ShopText.
|  |
|
Matt joined Connecticut Innovations in 2005 and is responsible for making new investments in Connecticut-based bioscience companies and managing many of CI's current bioscience investments. In his role as managing director, investments, he serves on the board of directors of several CI portfolio companies.
Matt brought to CI broad-based experiences in the life science, medical device and healthcare arenas. He was a co-founder of CompreMedx Cancer Centers Corporation and Health Excel Management, Inc., both healthcare services companies, and was a co-owner of Kramex Corporation, a radiology equipment supplier. Matt also served on the board of directors or in management capacities for a variety of bioscience companies - focused on robotics, healthcare services, and medical devices. Additionally, he made venture capital investments in medical device companies while at GTE New Ventures Corporation.
Matt has also shared his business experiences in an academic setting, having served as the first executive director of the Entrepreneurship and Small Business Management Institute at Quinnipiac University and served on the faculty of the Albert Einstein College of Medicine of Yeshiva University.
Matt holds both a master's degree in business administration and a bachelor's degree from Boston University.
Matt is a member of the board of Oxford Performance Materials, Inc., SPOC, Inc., Standing Stone, Inc., and PhytoCeutica, Inc. He is a board observer of GenCell, Inc.
|  |
|
Russell has been with Connecticut Innovations and its predecessor organization since 1985. Prior to joining CI, he was director of data processing for Scientific Leasing Inc. and the Robert E. Nolan Co. Russell also spent 20 years in various positions with United Technologies Corp. Russell has a background in economic and venture analysis, engineering cost accounting and systems analysis. His experience also includes scientific and commercial programming, math analysis, EDP auditing and computer modeling. Russ earned a bachelor's degree in electrical engineering and a master's degree in business administration from the University of Hartford.
Russ is a member of the board of Ipsogen, Inc. and a board observer of Ipsogen, SAS. He is also a board observer of Affomix.
|  |
|
Anil joined Connecticut Innovations in 2007, bringing with him more than ten years of experience in business strategy, operations, finance and business development in Fortune 500 high-technology and communications companies. As a senior consultant with the Internal Business Strategy Group at IBM Corporation, Anil evaluated investment opportunities in new technologies and worked on operations restructuring engagements to streamline business operations. As a manager at Oracle Corporation, Anil, led product development initiatives in industry leading e-business suite, led the solution implementation teams at several client engagements and participated in deals worth several millions of dollars. While pursuing his master’s degree in business administration, Anil also worked as a summer associate at TL Ventures, conducting industry research on software, Internet technology and other opportunities, and served as an intern with the video and media engineering group of Comcast Corporation, where he conducted market research on alternate multicasting platforms and evaluated new technologies for increasing broadcast bandwidth.
Anil graduated from Regional Engineering College, Durgapur, India, with a bachelor of engineering degree in chemical engineering and earned a master of business administration degree with majors in finance and strategic management from The Wharton School at the University of Pennsylvania.
Anil is a member of the board of ExeCue and Accumetrics.
|
 |
|
Dan joined Connecticut Innovations as an investment associate in 2007 and is responsible for evaluating opportunities, making investments and monitoring portfolio companies. Dan brought to CI over ten years of experience in the Connecticut biotech arena.
Prior to joining CI, Dan was employed by CuraGen Corporation, a successful former CI portfolio company. During his time at CuraGen, Dan held a variety of scientific and operational management positions. With extensive experience in research and development, technology assessment, and implementation of next generation scientific technologies, Dan helped transform CuraGen from a genomic and proteomic platform company into a biopharmaceutical firm dedicated to advancing its protein, antibody and small molecule therapeutics through preclinical and clinical development. Over the years, Dan has worked with various bioscience technologies, including those involved in DNA sequencing, gene expression analysis, proteomics, biomarker and SNP detection, process analytics, drug formulation, LIMS and bioinformatics development, and the production of protein and antibody therapeutics.
Dan graduated from the University of Dayton, earning a bachelor of science degree in biology. He also earned both a master of business administration degree and a master of health sciences degree, with a concentration in biomedical sciences, from Quinnipiac University.
|
|
|
|
|
